AFT Pharmaceuticals Limited

NZSE:AFT Stock Report

Market Cap: NZ$284.2m

AFT Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

AFT Pharmaceuticals has a total shareholder equity of NZ$83.5M and total debt of NZ$30.0M, which brings its debt-to-equity ratio to 36%. Its total assets and total liabilities are NZ$147.9M and NZ$64.4M respectively. AFT Pharmaceuticals's EBIT is NZ$19.2M making its interest coverage ratio 6.1. It has cash and short-term investments of NZ$10.7M.

Key information

36.0%

Debt to equity ratio

NZ$30.04m

Debt

Interest coverage ratio6.1x
CashNZ$10.69m
EquityNZ$83.53m
Total liabilitiesNZ$64.36m
Total assetsNZ$147.89m

Recent financial health updates

Recent updates

AFT Pharmaceuticals Limited (NZSE:AFT) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Nov 17
AFT Pharmaceuticals Limited (NZSE:AFT) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year

Jul 26
It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year

AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

May 25
AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?

May 22
Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?

Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?

Oct 17
Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?

Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?

May 23
Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?

Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?

Dec 01
Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?

We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise

Jul 30
We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise

With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For

Jun 02
With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For

Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?

Mar 20
Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?

A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation

Feb 13
A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation

Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 23
Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?

Jan 02
Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?

Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?

Dec 12
Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?

AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 21
AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Financial Position Analysis

Short Term Liabilities: AFT's short term assets (NZ$86.8M) exceed its short term liabilities (NZ$31.9M).

Long Term Liabilities: AFT's short term assets (NZ$86.8M) exceed its long term liabilities (NZ$32.4M).


Debt to Equity History and Analysis

Debt Level: AFT's net debt to equity ratio (23.2%) is considered satisfactory.

Reducing Debt: AFT's debt to equity ratio has reduced from 314.1% to 36% over the past 5 years.

Debt Coverage: AFT's debt is well covered by operating cash flow (85.7%).

Interest Coverage: AFT's interest payments on its debt are well covered by EBIT (6.1x coverage).


Balance Sheet


Discover healthy companies